SILO PHARMA INC (SILO) Stock Price, Quote, News and Overview
NASDAQ:SILO - Nasdaq - US82711P2011 - Common Stock - Currency: USD
SILO Quote, Performance and Key Statistics
SILO PHARMA INC
NASDAQ:SILO (2/10/2025, 8:23:04 PM)
After market: 1.53 -0.01 (-0.65%)1.54
-0.09 (-5.52%)
The current stock price of SILO is 1.54 USD. In the past month the price decreased by -12.99%. In the past year, price decreased by -0.65%.
SILO Latest News and Analysis
Silo Pharma Announces Positive Initial Pharmacokinetic, Safety, and Tolerability Study of SP-26 for Chronic Pain and Fibromyalgia
Silo Pharma Announces Positive Initial Pharmacokinetic, Safety, and Tolerability Study of SP-26 for Chronic Pain and Fibromyalgia
No serious side effects or discomfort observed Final safety and absorption data expected in March 2025 SARASOTA, FL, Feb. 11, 2025 (GLOBE NEWSWIRE) --...
Silo Pharma Advances Intellectual Property Portfolio with Provisional Patent Filing for PTSD Treatment
Silo Pharma Advances Intellectual Property Portfolio with Provisional Patent Filing for PTSD Treatment
SARASOTA, FL, Jan. 22, 2025 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or the “Company”), a developmental stage biopharmaceutical...
Silo Pharma Awarded US Patent for Groundbreaking PTSD Treatment and Prepares for SPC-15 Clinical Trial
SILO Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 18.81 | 336.36B | ||
| AMGN | AMGEN INC | 14.87 | 158.46B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 1620.59 | 121.03B | ||
| GILD | GILEAD SCIENCES INC | 21.55 | 118.99B | ||
| REGN | REGENERON PHARMACEUTICALS | 15.13 | 75.86B | ||
| ARGX | ARGENX SE - ADR | N/A | 38.66B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 35.35B | ||
| BNTX | BIONTECH SE-ADR | N/A | 27.63B | ||
| ONC | BEIGENE LTD-ADR | N/A | 23.41B | ||
| NTRA | NATERA INC | N/A | 22.73B | ||
| BIIB | BIOGEN INC | 8.73 | 20.77B | ||
| UTHR | UNITED THERAPEUTICS CORP | 15.18 | 15.43B |
Related stock screener links
About SILO
Company Profile
Silo Pharma, Inc. is a developmental stage biopharmaceutical company, which engages in the merging of traditional therapeutics with psychedelic research. The company is headquartered in Sarasota, Florida and currently employs 3 full-time employees. The company went IPO on 2012-01-05. The firm is focused on developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. The company is engaged in acquiring and/or developing intellectual property or technology rights from universities and researchers to treat rare diseases, including the use of psychedelic drugs, such as psilocybin, and the potential benefits they may have in certain cases involving depression, mental health issues and neurological disorders. The Company’s lead program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders. Its SP-26 is a time-release ketamine-loaded implant for fibromyalgia and chronic pain relief. Its two preclinical programs are SPC-14, an intranasal compound for the treatment of Alzheimer’s disease, and SPU-16, a CNS-homing peptide targeting multiple sclerosis (MS).
Company Info
SILO PHARMA INC
677 N. Washington Blvd
Sarasota FLORIDA US
Employees: 3
Company Website: https://silopharma.com/
Investor Relations: http://ir.silopharma.com
Phone: 17184009031
SILO FAQ
What is the stock price of SILO?
The current stock price of SILO is 1.54 USD.
What is the symbol for SILO PHARMA INC stock?
The exchange symbol of SILO PHARMA INC is SILO and it is listed on the Nasdaq exchange.
On which exchange is SILO stock listed?
SILO stock is listed on the Nasdaq exchange.
Is SILO a good stock to buy?
Always make your own analysis. On these pages you can find a full technical and fundamental analysis report for SILO, which may be a starting point for your analysis. You can also find the financials, news, analyst ratings and estimates here, which can be used to increase your understanding of SILO.
Does SILO stock pay dividends?
SILO does not pay a dividend.
When does SILO stock report earnings?
SILO will report earnings on 2025-05-12.
What is the Price/Earnings (PE) ratio of SILO?
SILO does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.18).
What is the Short Interest ratio of SILO stock?
The outstanding short interest for SILO is 23.9% of its float.
SILO Technical Analysis
ChartMill assigns a technical rating of 7 / 10 to SILO. When comparing the yearly performance of all stocks, SILO is one of the better performing stocks in the market, outperforming 81.49% of all stocks.
SILO Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to SILO. While SILO has a great health rating, there are worries on its profitability.
SILO Financial Highlights
Over the last trailing twelve months SILO reported a non-GAAP Earnings per Share(EPS) of -1.18. The EPS decreased by 11.88% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -44.16% | ||
| ROE | -55.78% | ||
| Debt/Equity | 0 |
SILO Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 83% to SILO. The Buy consensus is the average rating of analysts ratings from 7 analysts.